$1.02
0.010.99%
Pre-Market: Mar 13, 7:13 AM EDT
Comments
Loading...
Barinthus Biotherapeutics Earnings Estimates, EPS & Revenue | NASDAQ:BRNS | Benzinga
Barinthus Biotherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 12
EPS Estimate
$-0.450
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$14.97M
Analyze the earnings history of Barinthus Biotherapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BRNS | Barinthus Biotherapeutics | -$0.40 | -$0.45 | — | — | $0.00 | — | — | — | 05/12/2025 | Get Alert |
| BRNS | Barinthus Biotherapeutics | -$0.45 | -$0.46 | -$0.51 | -10.87% | $0.00 | — | $0.00 | — | 03/20/2025 | Get Alert |
| BRNS | Barinthus Biotherapeutics | -$0.37 | -$0.44 | -$0.21 | 52.27% | $0.00 | — | $14.97M | — | 11/06/2024 | Get Alert |
| BRNS | Barinthus Biotherapeutics | -$0.62 | -$0.41 | -$0.43 | -4.88% | $334.00K | — | $0.00 | — | 08/08/2024 | Get Alert |
| BRNS | Barinthus Biotherapeutics | -$0.48 | -$0.54 | -$0.40 | 25.93% | $468.00K | $130.00K | $0.00 | -100.00% | 05/13/2024 | Get Alert |
| BRNS | Barinthus Biotherapeutics | -$0.55 | -$0.50 | -$0.45 | 10.00% | $6.46M | $130.00K | $0.00 | -100.00% | 03/20/2024 | Get Alert |
| BRNS | Barinthus Biotherapeutics | $0.22 | -$0.53 | -$0.37 | 30.19% | $6.17M | — | $0.00 | — | 11/09/2023 | Get Alert |
| BRNS | Barinthus Biotherapeutics | $0.41 | -$0.55 | -$0.62 | -12.73% | $17.06M | $600.00K | $334.00K | -44.33% | 08/10/2023 | Get Alert |
| BRNS | Barinthus Biotherapeutics | $0.07 | -$0.50 | -$0.48 | 4.00% | $15.02M | $1.50M | $468.00K | -68.80% | 05/12/2023 | Get Alert |
| BRNS | Barinthus Biotherapeutics | -$0.38 | -$0.42 | -$0.55 | -30.95% | $0.00 | $41.35M | $6.46M | -84.38% | 03/24/2023 | Get Alert |
| BRNS | Barinthus Biotherapeutics | -$0.13 | -$0.33 | $0.22 | 166.67% | $19.00K | $7.82M | $6.17M | -21.16% | 11/10/2022 | Get Alert |
| BRNS | Barinthus Biotherapeutics | -$0.64 | -$0.39 | $0.41 | 205.13% | $35.00K | — | $17.06M | — | 08/09/2022 | Get Alert |
| BRNS | Barinthus Biotherapeutics | -$1.90 | -$0.31 | $0.07 | 122.58% | $215.00K | $3.57M | $15.02M | 320.67% | 05/11/2022 | Get Alert |
| BRNS | Barinthus Biotherapeutics | — | -$0.31 | -$0.38 | -22.58% | — | $410.00K | $0.00 | -100.00% | 03/25/2022 | Get Alert |
| BRNS | Barinthus Biotherapeutics | — | -$0.45 | -$0.13 | 71.11% | — | $1.10M | $19.00K | -98.27% | 11/12/2021 | Get Alert |
| BRNS | Barinthus Biotherapeutics | — | -$0.74 | -$0.64 | 13.51% | — | $100.00K | $35.00K | -65.00% | 08/12/2021 | Get Alert |
| BRNS | Vaccitech | — | — | -$1.90 | — | — | — | $215.00K | — | 06/14/2021 | Get Alert |
Barinthus Biotherapeutics (BRNS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-20 | $-0.51 | $-0.46 | -10.9 % |
| Q3 | 2024-11-06 | $-0.21 | $-0.44 | 52.3 % |
| Q2 | 2024-08-08 | $-0.43 | $-0.41 | -4.88 % |
| Q1 | 2024-05-13 | $-0.40 | $-0.54 | 25.9 % |
Barinthus Biotherapeutics (BRNS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2024-05-13 | $0 | $130.00K | -100.0 % |
| Q4 | 2024-03-20 | $0 | $130.00K | -100.0 % |
| Q2 | 2023-08-10 | $334.00K | $600.00K | -44.3 % |
| Q1 | 2023-05-12 | $468.00K | $1.50M | -68.8 % |
FAQ
When is Barinthus Biotherapeutics (NASDAQ:BRNS) reporting earnings?
Barinthus Biotherapeutics (BRNS) is scheduled to report earnings on May 12, 2025. The last reported earnings were for reported on March 20, 2025 for Q4.
What were the latest earnings per share (EPS) for Barinthus Biotherapeutics (NASDAQ:BRNS)?
The Actual EPS was $-0.51, which missed the estimate of $-0.46.
What were Barinthus Biotherapeutics’s (NASDAQ:BRNS) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.